Latest Headlines
-
HKUST Neuroscientists Develop Highly Accurate Universal Diagnostic Blood Test For Alzheimer's Disease And Mild Cognitive Impairment
2/19/2024
An HKUST-led international research collaboration has achieved a significant milestone in Alzheimer's disease (AD) diagnosis and management. The team, spearheaded by Prof. Nancy IP, President and the Morningside Professor of Life Science at the Hong Kong University of Science and Technology (HKUST), and Director of the Hong Kong Center for Neurodegenerative Diseases (HKCeND), has developed a cutting-edge blood test for the early detection of AD and mild cognitive impairment (MCI), surpassing remarkable accuracy rates of over 96% and 87% respectively.
-
Cutting Edge AI Company Gedicube And Cyclomics Sign Binding LOI To Join Forces And Position Themselves At The Forefront Of The Global Liquid Biopsy Marketplace
2/15/2024
GEDiCube (moving forward RenovaroCube), a London and Netherlands-based advanced AI company and a wholly owned subsidiary of Renovaro Inc. (NASDAQ: RENB), announces it has executed a binding Letter of Intent (LOI) to acquire 75% of Cyclomics, a Dutch Company. Under the terms of the LOI, the parties have agreed to work in good faith on the drafting of a definitive agreement.
-
Pharus Diagnostics Signs Worldwide Exclusive License Agreement With City Of Hope For Novel Biomarkers To Be Used In Liquid Biopsy Screening For Early Pancreatic Cancer Diagnosis
2/15/2024
Pharus Diagnostics ("PharusDx") today announced a global exclusive license agreement with City of Hope cancer center for proprietary biomarkers to be used in early screening of individuals at risk for pancreatic ductal adenocarcinoma (PDAC).
-
Data Innovations Releases Lab GPS v2.1
2/14/2024
Data Innovations announces the availability of Lab GPS™ v2.1., which introduces a new mobile app and other enhancements to enterprise lab uptime monitoring and optimization through its truly vendor-neutral connectivity platform, Instrument Manager™ (IM).
-
Sky Labs' CART BP Becomes The World's First To Complete Comparative Studies With All Blood Pressure Measurement Methods
2/14/2024
CART BP is a ring-type 24/7 blood pressure monitor of the global healthcare startup Sky Labs(CEO Jack, Lee), and has fully established itself as the only ring-type wearable medical device to complete comparative studies with all blood pressure measurement methods, becoming the first in the world.
-
Thermo Fisher Scientific Expands GMP Laboratory Service Offerings With Biosafety Testing Including Mycoplasma Testing
2/13/2024
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, is adding mycoplasma and additional biosafety testing capabilities to its expanding portfolio of services at its good manufacturing practices (GMP) lab in Middleton, Wisconsin.
-
Keystone Lab Announces Addition Of Tianeptine To Testing Menu
2/13/2024
Keystone Lab, a dual-CAP accredited and CLIA certified lab based in Asheville, NC, has officially added tianeptine to its in-house urine clinical toxicology menu. Keystone provides clinical and forensic toxicology testing services throughout the southeastern U.S. and is one of few labs in the southeast to offer testing for tianeptine.
-
Quest Diagnostics Debuts MelaNodal Predict™ Test, Personalizing Melanoma Risk Prediction To Help Patients Forgo Invasive Surgery
2/13/2024
Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced the launch of MelaNodal Predict™, a highly advanced predictive gene expression test to help personalize treatment decisions for patients with melanoma, the deadliest form of skin cancer and one of the most common cancers in the United States.
-
Roche Enters Into Collaboration Agreement With PathAI To Expand Digital Pathology Capabilities For Companion Diagnostics
2/13/2024
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has entered into an agreement with PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology.
-
Wasatch Biolabs Launches Proprietary Targeted DNA Methylation Sequencing Service For Researchers And Healthcare Providers
2/13/2024
Wasatch Biolabs (WBL), a subsidiary of Renew Biotechnologies and a certified Oxford Nanopore Technologies' laboratory, launches a proprietary Targeted DNA Methylation Sequencing Service for researchers and clinical service providers.